Endocrinology
RSSArticles
Insulin Glargine-yfgn Injection (Semglee)
Researchers Find Lower Amyloid Levels in Patients on Blood Sugar Control Drug
An investigation reveals an interesting trait among those taking a common diabetes management solution.Finerenone Tablets (Kerendia)
Finerenone can be prescribed to lower the risk of sustained estimated glomerular filtration rate decline, cardiovascular death, non-fatal myocardial infarction, end-stage kidney disease, and hospitalization from heart failure in adults with chronic kidney disease associated with type 2 diabetes.Common Herbal and Dietary Supplements for Patients with Type 2 Diabetes: Part 2
The authors review chromium, cinnamon, fenugreek, garlic, and Gymnema sylvestre as complementary and alternative medicine supplements for managing type 2 diabetes.Common Herbal and Dietary Supplements for Patients with Type 2 Diabetes
This is a review of the current literature regarding commonly used herbal and dietary supplements among people with diabetes.Loneliness and Type 2 Diabetes Incidence
Loneliness appears to be an independent risk factor for type 2 diabetes, although further research to identify the causal relationship between loneliness and type 2 diabetes development is needed.Exercise Intervention for Improving Metabolic-Associated Fatty Liver Disease
Researchers assessed the histological appearance of liver biopsies from patients with metabolic-associated fatty liver disease (MAFLD) who completed 12 weeks of structured and supported aerobic exercise. Compared to biopsies from a nonexercising control group, the intervention arm demonstrated some reversal of histopathologic changes caused by MAFLD.
Dasiglucagon Injection (Zegalogue)
Dasiglucagon should be prescribed to treat severe hypoglycemia in pediatric and adult patients (≥ age 6 years).
Is Metformin a Wonder Drug?
An analysis of patients taking metformin for diabetes showed they were less likely to report back, knee, neck/shoulder, or multisite musculoskeletal pain.
Insulin Pen Project Improves Patient Safety with EMR Modification
Staff at a Maryland hospital discovered a patient safety issue with insulin pens that was traced to the electronic medical record’s (EMR) inability to generate patient-specific labels efficiently. A root cause analysis revealed the process gaps, and staff developed a solution that ensures patients receive insulin doses only from their own pens.